P304 Docetaxel, carboplatin and weekly trastuzumab are active as neoadjuvant therapy in operable HER2-positive breast cancer

✍ Scribed by H.-C. Kolberg; L. Akpolat-Basci; F. Otterbach; A. Drumm; C. Tirier

• Book ID: 114316641
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 36 KB
• Volume: 20
• Category: Article
• ISSN: 0960-9776
• DOI: 10.1016/s0960-9776(11)70244-2